Exploring Current Treatment Practices in NSCLC

EP. 1: Molecular Testing in Non-Small Cell Lung Cancer

February 27th 2015

EP. 2: First-Line Therapy in EGFR-Mutant Lung Cancer

February 27th 2015

EP. 3: Bevacizumab in Non-Small Cell Lung Cancer

February 27th 2015

EP. 4: Overcoming EGFR Inhibitor Resistance in NSCLC

February 27th 2015

EP. 5: Types of EGFR Therapy in NSCLC

February 27th 2015

EP. 6: ALK Inhibition in NSCLC

February 27th 2015

EP. 7: Treatments for ALK-Positive NSCLC

February 27th 2015

EP. 8: Novel ALK Inhibitors in NSCLC With Brain Metastases

February 27th 2015

EP. 9: Treating Driver Mutation Negative NSCLC

February 27th 2015

EP. 10: Chemotherapy Regimens in Metastatic NSCLC

February 27th 2015

EP. 11: Maintenance Combination Therapy in NSCLC

February 27th 2015

EP. 12: Ramucirumab in Metastatic NSCLC

February 27th 2015

EP. 13: Necitumumab in Squamous NSCLC

February 27th 2015

EP. 14: Checkpoint Inhibition for Mesothelioma, Thymic Malignancies

February 27th 2015

x